18.11.2015 • NewsElaine Burridgeerdosteinedaewoong

Recipharm Extends Erdosteine API Pact with Daewoong

Sweden’s Recipharm has agreed to extend a manufacturing and supply agreement for Erdosteine API with Korean drugs firm Daewoong Pharmaceutical. The existing contract has been extended by 10 years through to 2025. Under the terms, Daewoong will buy minimum quantities of Erdosteine API worth around €25 million a year from Recipharm group company Edmond Pharma. In return, Daewoong will get exclusive rights to sell the original product in Korea and Thailand and to register and market all new Erdosteine products Edmond Pharma is currently developing.

Erdosteine, a treatment for acute and chronic respiratory diseases, has a unique mechanism of action. It is a mucolitic with anti-bacterial, anti-inflammatory and anti-oxidant characteristics. Currently, 75% of Erdosteine sold worldwide is supplied by Edmond Pharma.

Pierfrancesco Manzo, Recipharm’s sales and business development director for Erdosteine, said the agreement provides the basis for significant new growth in Korea. Sold under the name Erdos, the product is a leading respiratory treatment in Korea with around 46 million capsules and 700,000 suspensions sold in 2014.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.